Hypoxia regulates the adenosine transporter, mENT1, in the murine cardiomyocyte cell line, HL-1

Cardiovascular Research

Volumn 61, Issue 4, 2004, Pages 780-788

  Chaudary, Naz ^a   Naydenova, Zlatina ^a   Shuralyova, Irina ^a   Coe, Imogen R ^a  

^a YORK UNIVERSITY   (Canada)

Author keywords

Adenosine transporter; Cardiomyocytes; HL 1; mENT1; PKC; Regulation

Indexed keywords

ADENOSINE; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; ISOPROTEIN; LACTATE DEHYDROGENASE; MESSENGER RNA; NITROBENZYLTHIOINOSINE; PHORBOL ESTER; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON;

ANIMAL CELL; ARTICLE; CELL LINE; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME RELEASE; GLUCOSE TRANSPORT; HEART MUSCLE CELL; HYPOXIA; MEASUREMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN TRANSPORT; REGULATORY MECHANISM;

ANGIOTENSIN I; ANIMALS; ANOXIA; CELL LINE; ENZYME ACTIVATION; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; MICE; MICE, TRANSGENIC; MYOCYTES, CARDIAC; PROTEIN KINASE C;

EID: 1342281652     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2003.11.031     Document Type: Article

References (43)

1. Chatap G., Giraud K., Vincent J.P. Atrial fibrillation in the elderly: facts and management. Drugs Aging. 19:2002;819-846.
2. de Jong J.W., de Jonge R., Keijzer E., Bradamante S. The role of adenosine in preconditioning. Pharmacol. Ther. 87:2000;141-149.
3. Mubagwa K., Flameng W. Adenosine, adenosine receptors and myocardial protection: an updated overview. Cardiovasc. Res. 52:2001;25-39.
4. Peart J., Flood A., Linden J., Matherne G.P., Headrick J.P. Adenosine-mediated cardioprotection in ischemic-reperfused mouse heart. J. Cardiovasc. Pharmacol. 39:2002;117-129.
5. Shryock J.C., Belardinelli L. Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology and pharmacology. Am. J. Cardiol. 79:1997;2-10.
6. Olah M.E., Stiles G.L. Adenosine receptor subtypes: characterization and therapeutic regulation. Annu. Rev. Pharmacol. Ther. 35:1995;581-606.
7. Pennycooke M., Chaudary N., Shuralyova I., Zhang Y., Coe I.R. Differential expression of human nucleoside transporters in normal and tumor tissue. Biochem. Biophys. Res. Commun. 280:2001;951-959.
8. Szkotak A.J., Ng A.M.L., Sawicka J., et al. Regulation of K+ current in human airway epithelial cells by exogenous and autocrine adenosine. Am. J. Physiol. 281:2001;1991-2002.
9. Bailey A., Matthes H., Kieffer B., Slowe S., Hourani S.M.O., Kitchen I. Quantitative autoradiography of adenosine receptors and NBTI-sensitive adenosine transporters in the brains and spinal cords of mice deficient in the m-opioid receptor gene. Brain Res. 943:2002;68-79.
10. Coe I.R., Meckling K.A. Regulation of nucleoside transporters: from gene to protein. Pandalai S.G. Recent Research Developments in Nucleosides and Nucleotides. 2003;1-16 Transworld Research Network, Kerala.
11. Claycomb W.C., Lanson N.A., Stallworth B.S. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc. Natl. Acad. Sci. U. S. A. 95:1998;2979-2984.
12. Chaudary N., Shuralyova I., Liron T., Sweeney G., Coe I.R. Transport characteristics of HL-1 cells: a new model for the study of adenosine physiology in cardiomyocytes. Biochem. Cell Biol. 80:2002;655-665.
13. Neilan C.L., Kenyon E., Kovach M.A., et al. An immortalized myocyte cell line, HL1, express a functional d-opioid receptor. J. Mol. Cell. Cardiol. 32:2000;2187-2193.
14. Nguyen S.U., Claycomb W.C. Hypoxia regulates the expression of the adrenomedullin and HIF-1 genes in cultured HL-1 cardiomyocytes. Biochem. Biophys. Res. Comm. 265:1999;382-386.
15. Ostadal B., Ostadalova I., Dhalla N.S. Development of cardiac sensitivity to oxygen deficiency: comparative and ontogenetic aspects. Physiol. Rev. 79:1999;635-659.
16. Cormier-Regard S., Nguyen S.V., Claycomb W.C. Adrenomedullin gene expression is developmentally regulated and induced by hypoxia in rat ventricular cardiac myocytes. J. Biol. Chem. 273:1998;17787-17792.
17. Cai H., Smola U., Wixler V., et al. Role of diacylglycerol-regulated protein kinase C isotypes in growth factor activation of the Raf-1 protein kinase. Mol. Cell. Biol. 17:1997;732-741.
18. Safran N., Shneyvays V., Balas N., Jacobsen K.A., Nawrath H., Shainberg A. Cardioprotective effects of adenosine A1 and A3 receptor activation during hypoxia in isolated rat cardiac myocytes. Mol. Cell. Biochem. 217:2001;143-152.
19. Peart J., Headrick J.P. Adenosine-mediated early preconditioning in mouse: protective signaling and concentration dependent effects. Cardiovasc. Res. 58:2003;589-601.
20. Doria-Medina C.L., Lund D.D., Pasley A., Sandra A., Sivitz W.I. Immunolocalization of GLUT-1 glucose transporter in rat skeletal muscle and in normal and hypoxic cardiac tissue. Am. J. Physiol. 265:1993;454-464.
21. Behrooz A., Ismail-Beigi F. Dual control of glut1 glucose transporter gene expression by hypoxia and by inhibition of oxidative phosphorylation. J. Biol. Chem. 272:1997;5555-5562.
22. Coe I., Zhang Y., McKenzie T., Naydenova Z. PKC regulation of the human equilibrative nucleoside transporter hENT1. FEBS Lett. 517:2002;201-205.
23. Dorn G.W. II, Souroujon M.C., Liron L.T., et al. Sustained in vivo cardiac protection by a rationally designed peptide that causes e protein kinase C translocation. Proc. Natl. Acad. Sci. U. S. A. 96:1999;12793-12803.
24. Karliner J.S., Honbo N., Epstein C.J., Xian M., Lau Y.-F.C., Gray M.O. Neonatal mouse cardiac myocytes exhibit cardioprotection induced by hypoxic and pharmacologic preconditioning and by transgenic overexpression of human Cu/Zn superoxide dismutase. J. Mol. Cell. Cardiol. 32:2000;1779-1786.
25. Gray M.O., Karliner J.S., Mochly-Rosen D. A selective epsilon-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. J. Biol. Chem. 272:1997;30945-30951.
26. Eblenkamp M., Bottcher U., Thomoas J., et al. The effect of anoxia on cardiomyocyte glucose transport does not involve an adenosine release or a change in energy state. Life Sci. 59:1996;141-151.
27. Burgman P., Odonoghue J.A., Humm J.L., Ling C.C. Hypoxia-induced increase in FDG uptake in MCF-7 cells. J. Nucl. Med. 42:2001;170-175.
28. Boado R.J., Li J.Y., Tsukamoto H., Pardridge W.M. Hypoxia induces de-stabilization of the LAT1 large neutral amino acid transporter mRNA in brain capillary endothelial cells. J. Neurochem. 85:2003;1037-1042.
29. Mani R.S., Hammond J.R., Marjam J.M., et al. Demonstration of equilibrative nucleoside transporters (hENT1 and hENT2) in nuclear envelopes of cultured human choriocarcinoma (BeWo) cells by functional reconstitution in proteoliposomes. J. Biol. Chem. 273:1998;30818-30825.
30. Liang L., Johnstone R.M. Evidence for an internal pool of nucleoside transporters in mammalian reticulocytes. Biochim. Biophys. Acta. 1106:1992;89-196.
31. Mangravite L.M., Xiao G., Giacomini K.M. Localization of human equilibrative nucleoside transporters, hENT1 and hENT2, in renal epithelial cells. Am. J. Physiol. Renal Physiol. 284:2003;F902-F910.
32. Lai Y., Bakken A.H., Unadkat J.D. Simultaneous expression of hCNT1-CFP and hENT1-YFP in Mardin-Darby canine kidney (MDCK) cells: localization and vectorial transport studies. J. Biol. Chem. 277:2002;37711-37717.
33. Reiman T., Clarke M.L., Dabbagh L., et al. Differential expression of human equilibrative nucleoside transporter 1 (hENT1) protein in the Reed-Sternberg cells of Hodgkin's disease. Leuk. Lymphoma. 43:2002;1435-1440.
34. Zahniser N.R., Doolen S. Chronic and acute regulation of Na+/ Cl-dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol. Ther. 92:2001;21-55.
35. Furtado L.M., Poon V., Klip A. GLUT4 activation: thoughts on possible mechanisms. Acta Physiol. Scand. 178:2003;287-296.
36. Mackay K., Mochly-Rosen D. Localization, anchoring, and functions of protein kinase C isozymes in the heart. J. Mol. Cell. Cardiol. 33:2001;1301-1307.
37. Goldberg M., Zhang H.L., Steinberg S.F. Hypoxia alters the subcellular distribution of protein kinase C isoforms in neonatal rat ventricular myocytes. J. Clin. Invest. 99:1997;55-61.
38. Disatnik M.-H., Buraggi G., Mochly-Rosen D. Localization of protein kinase C isozymes in cardiac myocytes. Exp. Cell Res. 210:1994;287-297.
39. Casey T.M., Pakay J.L., Guppy M., Arthur P.G. Hypoxia causes downregulation of protein and RNA synthesis in noncontracting mammalian cardiomyocytes. Circ. Res. 90:2002;777-783.
40. Molina-Arcas M., Bellosillo B., Casado F.J., et al. Fludarabine uptake mechanisms in B-cell chronic lumphocytic leukemia. Blood. 101:2003;2328-2334.
41. Kobayshi S., Zimmermann H., Millhorn D.E. Chronic hypoxia enhances adenosine release in rat PC12 cells by altering adenosine metabolism and membrane transport. J. Neurochem. 74:2000;621-632.
42. Egert S., Nguyen N., Schwaiger M. Myocardial glucose transporter GLUT1: translocation by insulin and ischemia. J. Mol. Cell. Cardiol. 1999;1337-1344.
43. Crawford C.R., Patel D.H., Naeve C., Belt J.A. Cloning of the human equilibrative, nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter ei by functional expression in a transport-deficient cell line. J. Biol. Chem. 273:1998;5288-5293.